Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland

NCT01100853 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01100853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01100853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland
Lead sponsor
University of Pennsylvania
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2010
Completion date
February 28, 2013
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amphetamine dependence